Mena FN

Zuellig Pharma And Substipharm Biologics Partner To Expand Access To IMOJEV Vaccine For Japanese Encephalitis Across Asia

data-text="Zuellig Pharma and Substipharm Biologics partner to expand access to IMOJEV vaccine for Japanese encephalitis across Asia" data-link=" Pharma and Substipharm Biologics partner to expand ...
Yahoo Finance

Medigen Vaccine Biologics Corp Collaborates with Substipharm Biologics Expanding ENVACGEN® Enterovirus A71 Vaccine Market in Southeast Asia

Medigen Vaccine Biologics Corp (MVC) has signed a regional distribution agreement with the pharmaceutical company Substipharm Biologics to expand the market reach of enterovirus vaccine products in ...
Taiwan News

Medigen Vaccine Biologics Corp Collaborates with Substipharm Biologics Expanding ENVACGEN® Enterovirus A71 Vaccine Market in Southeast Asia

Fabrice Baschiera, CEO of Substipharm Biologics, stated: "We are dedicated to providing high-quality vaccines to protect children from life-threatening diseases. With Vietnam facing a severe ...
sinchew

Zuellig Pharma and Substipharm Biologics partner to expand access to IMOJEV® vaccine for Japanese encephalitis across Asia

SINGAPORE – Media OutReach Newswire – 16 January 2024 – Zuellig Pharma, a leading healthcare solutions company in Asia, has announced its commercialisation partnership with pharmaceutical company ...
manilatimes

Medigen Vaccine Biologics Corp Collaborates with Substipharm Biologics Expanding ENVACGEN® Enterovirus A71 Vaccine Market in Southeast Asia

Leo Lee, CEO of Medigen Vaccine, remarked: "Our partnership with Substipharm Biologics is a critical milestone. Substipharm Biologics brings expertise, credibility, and a strong reputation in the ...